cupure logo
Novo Nordisk Sues Eli Lilly Over Alleged Misleading Advertising for Obesity Drugs
Bfmtv

Novo Nordisk Sues Eli Lilly Over Alleged Misleading Advertising for Obesity Drugs

Novo Nordisk has filed a lawsuit against rival Eli Lilly in the U.S., alleging misleading advertising for its obesity treatments, including Zepbound and Mounjaro. The legal action occurs amid intense competition in the multi-billion dollar weight-loss drug market.

Comments

Read this story in other languages

Covered by the press in 5 countries

Among the outlets we follow

  • Spain4
  • France1
  • Germany1
  • Netherlands1
  • United States1

Similar News from External Sources

How we write our stories →

Cupure writes the day's most important stories in seven languages. The name comes from the French 'coupure de journal' — a newspaper clipping — our promise of concise, relevant news.

For advertising inquiries, content suggestions, or to flag a concern about a news item or content, you can reach us. We value your feedback. Contact form